Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth
Primary Purpose
Dentin Hypersensitivity, Active Dental Caries
Status
Completed
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
38% Silver Fluoride and Potassium Iodide solution (generic name; Riva Star®)
Sodium fluoride varnish (generic name; Duraphat®)
Sponsored by
About this trial
This is an interventional treatment trial for Dentin Hypersensitivity
Eligibility Criteria
Inclusion Criteria:
- Reported hypersensitivity in primary teeth associated with the presence of active carious lesions (ICDAS 5).
- Healthy children aged 2-5 years.
- Not using any desensitizer for 1-month prior the study.
- Willing to be examined.
Exclusion Criteria:
- Previously restored teeth.
- Teeth with signs or symptoms of irreversible pulpitis.
- Patients with any systemic disease requiring special considerations during their dental treatment.
- Parents/children who declined to participate in the study.
Sites / Locations
- The Department of Preventive and Pediatric Dentistry, University of Greifswald
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Fluoride varnish (Duraphat®)
Silver fluoride and potassium iodide (Riva Star®)
Arm Description
Fluoride varnish application is recommended by the German National Health System for managing hypersensitivity and dental caries. Sodium fluoride varnish (Duraphat®) will be applied on hypersensitive active carious lesions (ICDAS 5).
Silver fluoride and potassium iodide (Riva Star®) is primarily indicated for relieving hypersensitivity will be applied on hypersensitive active carious lesions (ICDAS 5) following isolation of the affected teeth and according to manufacturer's instructions.
Outcomes
Primary Outcome Measures
Hypersensitivity pain relief
The degree of pain severity will be quantified by a visual analogue scale - VAS; 0-10, ranging across a continuum from none (0) to a severe amount of pain (10).
Secondary Outcome Measures
Activity of carious lesions
Lesions will be assessed for caries activity using visual tactile criteria (Bjørndal Criteria; 0 - 9= sound -missing tooth) 0. Sound
Active lesion in enamel , without cavity ( bright surface with brown discoloration )
Active cavity in enamel ( opaque enamel surface and loss of substance )
Active cavity in enamel ( bright surface , brown discoloration, wet dentin )
Inactive cavity in enamel ( bright surface, brown discoloration and loss of substance )
Active cavity in enamel/dentin ( yellow or light brown discoloration , wet dentin )
Inactive cavity in enamel/dentin ( dark brown discoloration, hard and dry dentin )
Pulpal involvement or root stumps
Filled tooth
Missing tooth
Patient Acceptance
Children's behavior before, during and after treatment was assessed using Frankl's Scale
Definitely positive: Good rapport with the dentist, interested in the dental procedure, laughing and enjoying the situation
Positive: Acceptance of treatment; at time cautious, willingness to comply with the dentist, at times with reservation but patient follows the dentist's directions cooperatively
Negative: Reluctant to accept treatment; uncooperative, some evidence of negative attitude but not pronounced
Definitely negative: Refusal of treatment, crying forcefully, fearful, or any other overt evidence of extreme negativism
Operating Dentists' Opinion About the Procedure Performed
Dentist's technical opinion regarding the procedures and materials used in the study groups will be collected directly after performing the procedure using 5-point Likert scales.
Full Information
NCT ID
NCT04804423
First Posted
March 4, 2021
Last Updated
May 5, 2021
Sponsor
University Medicine Greifswald
Collaborators
SDI Limited
1. Study Identification
Unique Protocol Identification Number
NCT04804423
Brief Title
Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth
Official Title
Evaluation of the Efficacy of Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
January 13, 2020 (Actual)
Primary Completion Date
March 31, 2021 (Actual)
Study Completion Date
April 1, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Medicine Greifswald
Collaborators
SDI Limited
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This observational cohort study aims to evaluate the short-term (3 months) efficacy of the standard fluoride therapy in the German National Health System for managing hypersensitive carious lesions in primary teeth (fluoride varnish application), and further compare it to a different fluoride therapy utilizing a silver-containing fluoride agent combined with potassium iodide solution.
Detailed Description
A single trained investigator will screen for possible study participants of children aged 2-5 years old, and their parents will be asked to participate in the study. The participants will be consecutively recruited from regular clinic attendees of the Department of Preventive and Pediatric Dentistry at the University of Greifswald, from whom present with active carious lesions (ICDAS 5) along symptoms of hypersensitivity to be treated with fluoride varnish, and further compared to participants treated with silver fluoride and potassium iodide application.
Eligibility to the study will be determined by a single trained examiner through clinical findings of caries activity according to Bjørndal criteria, and reported history of hypersensitivity symptoms obtained from the parent/caregiver of the participant, followed by hypersensitivity confirmatory test using a triple syringe air blast on the exposed surface of the carious lesion to allocate areas with suspected dentin hypersensitivity.
After clinical examination and obtainment of an informed consent, eligible children will be treated with fluoride varnish application (Duraphat®), or silver fluoride and potassium iodide application (Riva Star®) according to manufacturer's instructions.The participant's behavior shall be evaluated at the beginning, during and after treatment. Plaque Index (API) and Papillary Bleeding Index (PBI) will also be assessed prior to treatment and at the 3-months mark. Procedures will be performed by six different dentists (four pediatric specialists and two post-graduate pediatric dentistry students), all of whom were briefed on the study protocol and received instructions in carrying in the interventions according to the manufacturer's guide, and their technical opinions regarding the performed procedures will be obtained following the procedure. Follow up examinations after 3 months will be done by a single examiner. Only one tooth per child will be included in the analysis.
Data and information of this study will be recorded, handled, and stored in an organized and secure way, to allow its accurate reporting, interpretation, and verification. To assure confidentiality of clinical records, an unambiguous subject identification code will be used. Patients who are no longer willing to continue in the study will have the right to quit at any time without any penalty.
All variables will be statistically analyzed using descriptive statistics, plots, and tests of normality. Means and standard deviations (SD) will be calculated for all quantitative variables, while frequencies and percentages will be calculated for categorical variables.
Comparison between the two study groups will utilize independent samples t-test for quantitative normally distributed variables, and Mann-Whitney U for quantitative non-normally distributed variables and qualitative ordinal variables. Chi-squared and Fisher exact tests will be performed for comparing qualitative nominal variables between the two study groups. Comparing the baseline and follow-up shall be done using paired t-test when the variable is normally distributed, and Wilcoxon signed rank test when the variable is not normally distributed. For comparing lesion activity before and after treatment, McNemar test will be used and Friedman test for comparing the children's behavior at 3 different time points (before, during and after treatment).
A Significance will be set at p<0.05. Data will be analyzed using IBM SPSS statistical software for windows (version 25).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dentin Hypersensitivity, Active Dental Caries
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fluoride varnish (Duraphat®)
Arm Type
Active Comparator
Arm Description
Fluoride varnish application is recommended by the German National Health System for managing hypersensitivity and dental caries. Sodium fluoride varnish (Duraphat®) will be applied on hypersensitive active carious lesions (ICDAS 5).
Arm Title
Silver fluoride and potassium iodide (Riva Star®)
Arm Type
Experimental
Arm Description
Silver fluoride and potassium iodide (Riva Star®) is primarily indicated for relieving hypersensitivity will be applied on hypersensitive active carious lesions (ICDAS 5) following isolation of the affected teeth and according to manufacturer's instructions.
Intervention Type
Drug
Intervention Name(s)
38% Silver Fluoride and Potassium Iodide solution (generic name; Riva Star®)
Other Intervention Name(s)
Riva Star®
Intervention Description
38% silver fluoride will be applied to the surface of the isolated hypersensitive carious lesion followed by application of potassium iodide solution and according to manufacturer's instructions.
Intervention Type
Drug
Intervention Name(s)
Sodium fluoride varnish (generic name; Duraphat®)
Other Intervention Name(s)
Duraphat®
Intervention Description
22,600 ppm sodium fluoride varnish will be applied on the surface of the affected hypersensitive active carious lesions.
Primary Outcome Measure Information:
Title
Hypersensitivity pain relief
Description
The degree of pain severity will be quantified by a visual analogue scale - VAS; 0-10, ranging across a continuum from none (0) to a severe amount of pain (10).
Time Frame
3 Months
Secondary Outcome Measure Information:
Title
Activity of carious lesions
Description
Lesions will be assessed for caries activity using visual tactile criteria (Bjørndal Criteria; 0 - 9= sound -missing tooth) 0. Sound
Active lesion in enamel , without cavity ( bright surface with brown discoloration )
Active cavity in enamel ( opaque enamel surface and loss of substance )
Active cavity in enamel ( bright surface , brown discoloration, wet dentin )
Inactive cavity in enamel ( bright surface, brown discoloration and loss of substance )
Active cavity in enamel/dentin ( yellow or light brown discoloration , wet dentin )
Inactive cavity in enamel/dentin ( dark brown discoloration, hard and dry dentin )
Pulpal involvement or root stumps
Filled tooth
Missing tooth
Time Frame
3 Months
Title
Patient Acceptance
Description
Children's behavior before, during and after treatment was assessed using Frankl's Scale
Definitely positive: Good rapport with the dentist, interested in the dental procedure, laughing and enjoying the situation
Positive: Acceptance of treatment; at time cautious, willingness to comply with the dentist, at times with reservation but patient follows the dentist's directions cooperatively
Negative: Reluctant to accept treatment; uncooperative, some evidence of negative attitude but not pronounced
Definitely negative: Refusal of treatment, crying forcefully, fearful, or any other overt evidence of extreme negativism
Time Frame
Only at baseline (begining, during and after procedure)
Title
Operating Dentists' Opinion About the Procedure Performed
Description
Dentist's technical opinion regarding the procedures and materials used in the study groups will be collected directly after performing the procedure using 5-point Likert scales.
Time Frame
Will be recorded immediately after the procedure
Other Pre-specified Outcome Measures:
Title
O'Leary Plaque Control Index
Description
Visual assessment of plaque covered surfaces following application of a disclosing solution. The number of positively scored surfaces is divided by the total number of tooth surfaces evaluated, and the result is multiplied by 100 to express the index as a percentage
O'Leary Palque Index will be clinically evaluated prior to treatment and at the 3-months follow up visit.
Time Frame
3 Months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Reported hypersensitivity in primary teeth associated with the presence of active carious lesions (ICDAS 5).
Healthy children aged 2-5 years.
Not using any desensitizer for 1-month prior the study.
Willing to be examined.
Exclusion Criteria:
Previously restored teeth.
Teeth with signs or symptoms of irreversible pulpitis.
Patients with any systemic disease requiring special considerations during their dental treatment.
Parents/children who declined to participate in the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohamed H Abudrya, BDS, MSc.
Organizational Affiliation
The Department of Preventive and Pediatric Dentistry, University of Greifswald
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Department of Preventive and Pediatric Dentistry, University of Greifswald
City
Greifswald
State/Province
Mecklenburg-Vorpommern
ZIP/Postal Code
17475
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
24993261
Citation
West N, Seong J, Davies M. Dentine hypersensitivity. Monogr Oral Sci. 2014;25:108-22. doi: 10.1159/000360749. Epub 2014 Jun 26.
Results Reference
background
PubMed Identifier
28457477
Citation
Crystal YO, Janal MN, Hamilton DS, Niederman R. Parental perceptions and acceptance of silver diamine fluoride staining. J Am Dent Assoc. 2017 Jul;148(7):510-518.e4. doi: 10.1016/j.adaj.2017.03.013. Epub 2017 Apr 27.
Results Reference
background
PubMed Identifier
32074885
Citation
Use of Silver Diamine Fluoride for Dental Caries Management in Children and Adolescents, Including Those with Special Health Care Needs. Pediatr Dent. 2018 Oct 15;40(6):152-161.
Results Reference
background
PubMed Identifier
26831727
Citation
Gao SS, Zhang S, Mei ML, Lo EC, Chu CH. Caries remineralisation and arresting effect in children by professionally applied fluoride treatment - a systematic review. BMC Oral Health. 2016 Feb 1;16:12. doi: 10.1186/s12903-016-0171-6.
Results Reference
background
PubMed Identifier
31590168
Citation
Machiulskiene V, Campus G, Carvalho JC, Dige I, Ekstrand KR, Jablonski-Momeni A, Maltz M, Manton DJ, Martignon S, Martinez-Mier EA, Pitts NB, Schulte AG, Splieth CH, Tenuta LMA, Ferreira Zandona A, Nyvad B. Terminology of Dental Caries and Dental Caries Management: Consensus Report of a Workshop Organized by ORCA and Cariology Research Group of IADR. Caries Res. 2020;54(1):7-14. doi: 10.1159/000503309. Epub 2019 Oct 7.
Results Reference
background
PubMed Identifier
11405992
Citation
Poulsen S, Errboe M, Hovgaard O, Worthington HW. Potassium nitrate toothpaste for dentine hypersensitivity. Cochrane Database Syst Rev. 2001;(2):CD001476. doi: 10.1002/14651858.CD001476.
Results Reference
background
PubMed Identifier
23224064
Citation
Splieth CH, Tachou A. Epidemiology of dentin hypersensitivity. Clin Oral Investig. 2013 Mar;17 Suppl 1(Suppl 1):S3-8. doi: 10.1007/s00784-012-0889-8. Epub 2012 Dec 7.
Results Reference
background
PubMed Identifier
29258064
Citation
Santamaria RM, Innes NPT, Machiulskiene V, Schmoeckel J, Alkilzy M, Splieth CH. Alternative Caries Management Options for Primary Molars: 2.5-Year Outcomes of a Randomised Clinical Trial. Caries Res. 2017;51(6):605-614. doi: 10.1159/000477855. Epub 2017 Dec 20.
Results Reference
background
PubMed Identifier
32854105
Citation
Santamaria RM, Abudrya MH, Gul G, Mourad MS, Gomez GF, Zandona AGF. How to Intervene in the Caries Process: Dentin Caries in Primary Teeth. Caries Res. 2020;54(4):306-323. doi: 10.1159/000508899. Epub 2020 Aug 27.
Results Reference
background
Links:
URL
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K102973
Description
DA: Food and Drug Administration. Diammine Silver Fluoride Dental Hypersensitivity Varnish.
Learn more about this trial
Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth
We'll reach out to this number within 24 hrs